Shore Capital Reaffirms "Hold" Rating for Assura (LON:AGR)

Key Points

• Shore Capital has reaffirmed its "hold" rating for Assura (LON:AGR), while Peel Hunt has reissued a "buy" rating with a price target of GBX 60.
• Assura's stock experienced a 2.5% rise, trading at GBX 48.40, and has a market capitalization of £1.57 billion.
• Insider transactions included the sale of over 5 million shares in the last ninety days, while insider ownership stands at 0.93% of the stock.

Assura (LON:AGR - Get Free Report)'s stock had its "hold" rating reaffirmed by stock analysts at Shore Capital in a research note issued to investors on Wednesday,Digital Look reports.

Separately, Peel Hunt reissued a "buy" rating and set a GBX 60 price objective on shares of Assura in a report on Tuesday. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of GBX 60.

Assura Trading Up 2.5%

AGR traded up GBX 1.16 on Wednesday, hitting GBX 48.40. The company had a trading volume of 83,858 shares, compared to its average volume of 25,262,914. The company has a market cap of £1.57 billion, a PE ratio of 913.21, a PEG ratio of 3.60 and a beta of 0.37. Assura has a 12-month low of GBX 35.24 and a 12-month high of GBX 50.95. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.05. The business's fifty day simple moving average is GBX 48.07 and its 200 day simple moving average is GBX 48.48.

Assura (LON:AGR - Get Free Report) last announced its quarterly earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 earnings per share (EPS) for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. Equities research analysts expect that Assura will post 3.5830389 EPS for the current year.

Insider Buying and Selling

In other news, insider Jayne Cottam sold 1,017,587 shares of Assura stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of GBX 50, for a total transaction of £508,793.50. Also, insider Sam Barrell sold 34,153 shares of Assura stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of GBX 48, for a total transaction of £16,393.44. In the last ninety days, insiders bought 2,540 shares of company stock worth $125,674 and sold 5,182,149 shares worth $258,872,495. 0.93% of the stock is currently owned by insiders.

About Assura

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.